Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04700254 |
Recruitment Status :
Completed
First Posted : January 7, 2021
Last Update Posted : January 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Diabetes Mellitus SARS-CoV-2 | Other: DASS questionnaire Other: EAT-26 questionnaire |
Study Type : | Observational |
Actual Enrollment : | 150 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | The Effect of COVID-19 National Lockdown on People With Diabetes Mellitus Regarding Their Anxiety, Depression and Eating Attitudes, in Relation to Adjusted Work and Family Conditions |
Actual Study Start Date : | December 28, 2020 |
Actual Primary Completion Date : | January 11, 2021 |
Actual Study Completion Date : | January 11, 2021 |

Group/Cohort | Intervention/treatment |
---|---|
working condition
In order to further explore the differences among working status the data will be categorized into three different groups: suspension of work, employment and unemployment.
|
Other: DASS questionnaire
The DASS is a 42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress Other: EAT-26 questionnaire The Eating Attitudes Test (EAT-26), is a self-report 26-item questionnaire of symptoms and concerns characteristic of eating disorders. |
Family status
In order to xplore the differences among the family status, the data will be categorized into the married and the singles DM patients.
|
Other: DASS questionnaire
The DASS is a 42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress Other: EAT-26 questionnaire The Eating Attitudes Test (EAT-26), is a self-report 26-item questionnaire of symptoms and concerns characteristic of eating disorders. |
BMI status
In order to further explore BMI scale results, we divided the data obtained from the participants into normal (18.50 - 24.99 kg/m2), overweight (25-29.99 kg/m2) and obese (≥30 kg/m2), according to the international classification of the World Health Organisation (WHO).
|
Other: DASS questionnaire
The DASS is a 42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress Other: EAT-26 questionnaire The Eating Attitudes Test (EAT-26), is a self-report 26-item questionnaire of symptoms and concerns characteristic of eating disorders. |
- DASS (Depression) [ Time Frame: Time Frame: Brief standardised questionnaire not exceeding 8 minutes. Administered during the data collection phase, no intervention involved, this is a cross-sectional observation study. ]Minimum score 0 maximum score 42 of the depression subscale of the DASS questionnaire Higher scores mean a worse outcome
- DASS (Anxiety) [ Time Frame: Time Frame: Brief standardised questionnaire not exceeding 8 minutes. Administered during the data collection phase, no intervention involved, this is a cross-sectional observation study. ]Minimum score 0 maximum score 42 of the anxiety subscale of the DASS questionnaire Higher scores mean a worse outcome
- Eating Attitudes Test (EAT-26) [ Time Frame: Time Frame: Brief standardised questionnaire not exceeding 8 minutes. Administered during the data collection phase, no intervention involved, this is a cross-sectional observation study. ]
Minimun score 0 maximum score 78 Scores greater than 20 indicate a need for further investigation by a qualified professional.
Low scores (below 20) can still be consistent with serious eating problems.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- age ≥18 years
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- MODY Diabetes Mellitus
Exclusion Criteria:
- age <18 years
- gestational Diabetes

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04700254
Greece | |
General Hospital of Chania | |
Chania, Crete, Greece, 73100 |
Responsible Party: | Chania General Hospital "St. George" |
ClinicalTrials.gov Identifier: | NCT04700254 |
Other Study ID Numbers: |
Diabetes and COVID-19 |
First Posted: | January 7, 2021 Key Record Dates |
Last Update Posted: | January 25, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | contact via e-mail |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Diabetes Mellitus Anxiety Depression Eating attitudes |
Diabetes Mellitus Depression Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Behavioral Symptoms |